Search results
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 6 days agoThe biotech company aims to bring as many as 15 new products to market over the next five years and has the late-stage pipeline to support...is set to...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 19 hours agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 21 hours agoSI&A spending is expected in the range of $13...billion to $14.8 billion. The adjusted tax rate is...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 3 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
FDA Says Vaccination Is the Best Protection Against Measles
Sierra Sun Times· 3 days agoMeasles is one of the most contagious respiratory diseases in the world that has the potential to be life-threatening. Vaccines approved by the U.S. Food and Drug Administration ...
Dow Jones Darling Merck Pops As Cancer 'Star' Drives Quarterly Beat
Investor's Business Daily· 7 days agoMerck's bread-and-butter cancer drug grew by double digits again in the first quarter.
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 7 days agoQuarter in Detail The Pharmaceutical segment generated revenues of $14.0 billion, up 9% year over...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 2 days agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals ...
First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer
Nature· 6 days agoDiscover the world’s best science and medicine | Nature.com
Health Care Roundup: Market Talk
The Wall Street Journal· 20 hours agoRead about GSK and Haleon in the latest Market Talks covering the Health Care sector.
